Insider Trading History of Brady Stephen R

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Brady Stephen R since 2016. This trader's CIK number is 1606241. At the time of last reporting, Brady Stephen R was the President and CEO of Tempest Therapeutics, Inc.. (stock ticker symbol TPST). Also see all insider trading activities at Tempest Therapeutics, Inc..

Note that in the past Brady Stephen R also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Immune Design Corp. (IMDZ) by Brady Stephen R

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 IMDZ 0 $0 5,516 $8,720 0 $0
2018 IMDZ 0 $0 3,328 $13,884 0 $0
2017 IMDZ 0 $0 1,642 $8,784 0 $0
2016 IMDZ 1,500 $10,255 0 $0 0 $0

Yearly summary of insider trading at Tempest Therapeutics, Inc. (TPST) by Brady Stephen R

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 TPST 35,000 $73,850 0 $0 0 $0


Insider trading activities at 2 companies by Brady Stephen R:

1. Immune Design Corp. (IMDZ)

2. Tempest Therapeutics, Inc. (TPST)

Table 1. Insider trading of Immune Design Corp. (IMDZ) by Brady Stephen R

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-01-07 IMDZ Sale 5,516 1.58 8,720
2018-01-05 IMDZ Sale 3,328 4.17 13,884
2017-01-04 IMDZ Sale 1,642 5.35 8,784
2016-07-15 IMDZ Buy 1,500 6.84 10,255

Table 2. Insider trading of Tempest Therapeutics, Inc. (TPST) by Brady Stephen R

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-07-03 TPST Buy 35,000 2.11 73,850

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Brady Stephen R (President and CEO of Tempest Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.